Teladoc Inc (NYSE:TDOC) hit a new 52-week high on Monday after SunTrust Banks raised their price target on the stock to $100.00. SunTrust Banks currently has a buy rating on the stock. Teladoc traded as high as $81.05 and last traded at $77.95, with a volume of 66452 shares. The stock had previously closed at $78.15.

A number of other equities research analysts have also weighed in on TDOC. Piper Jaffray Companies boosted their price objective on shares of Teladoc to $46.00 and gave the stock an “overweight” rating in a report on Monday, June 4th. Craig Hallum upgraded shares of Teladoc from a “hold” rating to a “buy” rating in a report on Tuesday, June 5th. JPMorgan Chase & Co. boosted their price objective on shares of Teladoc to $58.00 and gave the stock an “overweight” rating in a report on Tuesday, June 5th. Canaccord Genuity boosted their price objective on shares of Teladoc from $47.00 to $63.00 and gave the stock a “buy” rating in a report on Tuesday, June 5th. Finally, Cantor Fitzgerald boosted their price objective on shares of Teladoc from $35.00 to $50.00 and gave the stock a “neutral” rating in a report on Tuesday, June 5th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $67.80.

In related news, insider Stephany Verstraete sold 18,000 shares of the company’s stock in a transaction on Thursday, September 20th. The shares were sold at an average price of $74.79, for a total transaction of $1,346,220.00. Following the completion of the sale, the insider now directly owns 13,925 shares in the company, valued at approximately $1,041,450.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Adam C. Vandervoort sold 5,550 shares of the company’s stock in a transaction on Monday, September 10th. The shares were sold at an average price of $77.67, for a total transaction of $431,068.50. Following the sale, the insider now owns 2,934 shares of the company’s stock, valued at $227,883.78. The disclosure for this sale can be found here. Insiders have sold a total of 286,781 shares of company stock valued at $19,429,607 over the last quarter. 3.95% of the stock is currently owned by company insiders.

Large investors have recently bought and sold shares of the stock. We Are One Seven LLC increased its position in Teladoc by 241.1% during the 1st quarter. We Are One Seven LLC now owns 2,845 shares of the health services provider’s stock valued at $115,000 after purchasing an additional 2,011 shares during the period. Garner Asset Management Corp purchased a new position in Teladoc during the 2nd quarter valued at $200,000. Pier 88 Investment Partners LLC purchased a new position in Teladoc during the 2nd quarter valued at $201,000. Aperio Group LLC purchased a new position in Teladoc during the 2nd quarter valued at $201,000. Finally, California Public Employees Retirement System purchased a new position in Teladoc during the 2nd quarter valued at $203,000.

The company has a current ratio of 3.14, a quick ratio of 3.14 and a debt-to-equity ratio of 0.58. The stock has a market cap of $5.43 billion, a PE ratio of -49.09 and a beta of 0.57.

Teladoc (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, August 1st. The health services provider reported ($0.37) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.38) by $0.01. The business had revenue of $94.60 million for the quarter, compared to the consensus estimate of $91.56 million. Teladoc had a negative net margin of 37.78% and a negative return on equity of 19.10%. The company’s quarterly revenue was up 112.1% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.28) EPS. analysts anticipate that Teladoc Inc will post -1.51 EPS for the current year.

Teladoc Company Profile (NYSE:TDOC)

Teladoc, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Read More: How to Use a Moving Average for TradingĀ 

Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.